CN103965232B - A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester - Google Patents

A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester Download PDF

Info

Publication number
CN103965232B
CN103965232B CN201410166801.5A CN201410166801A CN103965232B CN 103965232 B CN103965232 B CN 103965232B CN 201410166801 A CN201410166801 A CN 201410166801A CN 103965232 B CN103965232 B CN 103965232B
Authority
CN
China
Prior art keywords
acid ester
dihydro
synthesis
boronic acid
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410166801.5A
Other languages
Chinese (zh)
Other versions
CN103965232A (en
Inventor
唐拥军
莫珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASLEE BIOPHARMACEUTICALS Inc
Original Assignee
ASLEE BIOPHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASLEE BIOPHARMACEUTICALS Inc filed Critical ASLEE BIOPHARMACEUTICALS Inc
Priority to CN201410166801.5A priority Critical patent/CN103965232B/en
Publication of CN103965232A publication Critical patent/CN103965232A/en
Application granted granted Critical
Publication of CN103965232B publication Critical patent/CN103965232B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention's open a kind of synthesis 3-(2,5-dihydro) method of furan boronic acid ester, relate to a kind of boric acid ester new synthetic method of medical intermediate, belong to organic chemical synthesis field.It is characterized in that: comprise 3-(2,5 dihydros) preparation of furane sulfonic acid ester and 3-(2,5-dihydro) synthesis of furan boronic acid ester.Its beneficial effect is: cost of material is cheaply easy to get, and reactions steps is simple, the gentle easily operation of processing condition, and technology stability is good, is easy to realize suitability for industrialized production, and aftertreatment is simple, and productive rate is high, and purity is good, and product cost is low.

Description

A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester
Technical field
The present invention relates to a kind of boric acid ester new synthetic method of medical intermediate, belong to organic chemical synthesis field, refer to a kind of synthesis 3-(2,5-dihydro especially) method of furan boronic acid ester.
Background technology
3-(2,5-dihydro) furan boronic acid ester as a kind of fine chemical material, be extensively used as medicine intermediate.Its synthetic method seldom reported by existing document, only have one section of article report its synthesis (its synthetic route is as follows for J.Am.Chem.Soc, 1998,120,7995 – 7996:
This synthetic route relates to three steps, as long as the productive rate of the first step 20%, the productive rate of second step is 15%, three step overall yields less than 20%, and use active high tert-butyl lithium, severe reaction conditions, not easy to operate, reaction reagent Grubbs ' catalyst wherein expensive ($ 250/g) is also not easy to have bought, and use this synthetic route can only synthesize the product of several milligrams in laboratory, and the cost of product is very high.In addition, the finished product of gained should be colourless liquids, but are all can not remove by column chromatography or underpressure distillation purifying the trace metal catalysts contained, and the product of gained is auburn liquid, product purity not high (94%).In a word, no matter this synthetic route is from reaction conditions and the chemical reagent used, and not only consume energy but also expensive, production cost is high, all can not realize amplifying preparation, more can not realize suitability for industrialized production.Between this situation, we are badly in need of the novel process will researching and developing this compou nd synthesis, shorten synthetic route, change reaction conditions, thus good product purity (98%), raw material is easy to get and low price, easily amplifies synthesis, realizes suitability for industrialized production.
Summary of the invention
The object of the invention is to overcome above-mentioned not enough problem, provide 3-(2,5-dihydro) new synthetic process of furan boronic acid ester, synthetic method is simple, and raw material is easy to get and low price, good product purity, stable performance, and production cost is low, easily realizes suitability for industrialized production.
The present invention for achieving the above object, one synthesis 3-(2,5-dihydro of the present invention) method of furan boronic acid ester, comprise 3-(2,5 dihydros) preparation of furane sulfonic acid ester and 3-(2,5-dihydro) synthesis of furan boronic acid ester, reaction formula is as follows:
One, 3-(2; 5 dihydros) preparation of furane sulfonic acid ester: under nitrogen protection; 50g is added, 0.58mol3-(2,5 dihydros in 1L reaction flask) furanone and the anhydrous THF of 200mL; be chilled to-78 DEG C; then 376mL is dripped, the anhydrous THF diisopropylamine lithium of 0.64mol, 1.7N in; reaction reacts 2h at-78 DEG C; be added dropwise to 163.9g again, 0.58mol tri-fluorosulfonic anhydride, dropwises; reaction solution is allowed slowly to rise to room temperature; whole process need 12h, with 10% sodium hydroxide cancellation reaction, adds 1L ether dilute reaction solution; be separated organic phase, use anhydrous MgSO 4drying, underpressure distillation, except desolventizing, under the vacuum condition of 12mmHg, is collected 45 ~ 50 DEG C of cuts, is namely obtained the 3-(2.5 dihydro of 98% purity) furane sulfonic acid ester;
Two, 3-(2; 5-dihydro) synthesis of furan boronic acid ester: under nitrogen protection; 64g is added, 0.29mol3-(2,5 dihydros in 1L reaction flask) furane sulfonic acid ester; 74.5g; 0.29mol joins boric acid ester, 73.1g, 0.87mol salt of wormwood; and 6.43g, 0.09mol catalyst P d (dppf) Cl 2, and solvent 500mL1,4-dioxane, in reaction solution, blast nitrogen 10min, then slow under a nitrogen reaction system is warming up to 80 DEG C, allow system react 16h at this temperature, be chilled to room temperature, filter, removal of solvent under reduced pressure, residue dress on a silica gel column, with normal hexane: ethyl acetate=10:1 eluted product, distillation, except desolventizing, obtains colourless oil liquid, obtains product.
Described whole reaction is carried out in inert nitrogen gas.
In described step one, 3-(2,5-dihydro) mol ratio of furanone and diisopropylamine lithium and three fluorosulfonic anhydride is: 1:1.1:1.
In described step 2,3-(2.5 dihydro) furane sulfonic acid ester with the mol ratio of connection boric acid ester and catalyzer is: 1:0.9:0.03.
In described step one, reaction end is monitored by GC, raw material and intermediate product 3-(2.5 dihydro) the GC content ratio of furane sulfonic acid ester is less than 1% judgement reaction end.
In described step 2, reaction end is monitored by GC, intermediate product 3-(2.5 dihydro) the GC content ratio of furane sulfonic acid ester and final product is less than 1% judgement reaction end.
The described 3-(2 prepared, 5-dihydro) furan boronic acid ester is a kind of medicine intermediate.
One synthesis 3-(2 of the present invention, 5-dihydro) method of furan boronic acid ester, its beneficial effect is: cost of material is cheaply easy to get, and reactions steps is simple, the gentle easily operation of processing condition, and technology stability is good, be easy to realize suitability for industrialized production, aftertreatment is simple, and productive rate is high, purity is good, and product cost is low.
Embodiment
Be clearly and completely described below in conjunction with the technical scheme in the embodiment of the present invention, obviously, described embodiment is only one of them embodiment of the present invention, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
One, 3-(2,5 dihydros) preparation of furane sulfonic acid ester:
Under nitrogen protection, in 1L reaction flask, 50g is added, 0.58mol3-(2; 5 dihydros) furanone and the anhydrous THF of 200mL, be chilled to-78 DEG C, then drip 376mL; the anhydrous THF diisopropylamine lithium of 0.64mol, 1.7N in, reacts and react 2h at-78 DEG C; be added dropwise to 163.9g again, 0.58mol tri-fluorosulfonic anhydride, dropwises; reaction solution is allowed slowly to rise to room temperature, whole process need 12h, with 10% sodium hydroxide cancellation reaction; add 1L ether dilute reaction solution, be separated organic phase, use anhydrous MgSO 4drying, underpressure distillation, except desolventizing, under the vacuum condition of 12mmHg, is collected 45 ~ 50 DEG C of cuts, is obtained 3-(2,5 dihydros) furane sulfonic acid ester;
Two, 3-(2,5-dihydro) synthesis of furan boronic acid ester:
Under nitrogen protection, in 1L reaction flask, add 64g, 0.29mol3-(2,5 dihydros) furane sulfonic acid ester, 74.5g, 0.29mol join boric acid ester, 73.1g, 0.87mol salt of wormwood, and 6.43g, 0.09mol catalyst P d (dppf) Cl 2, and solvent 500mL1,4-dioxane, in reaction solution, blast nitrogen 10min, then slow under a nitrogen reaction system is warming up to 80 DEG C, allow system react 16h at this temperature, be chilled to room temperature, filter, removal of solvent under reduced pressure, residue dress on a silica gel column, with normal hexane: ethyl acetate=10:1 eluted product, distillation is except desolventizing, and obtaining colourless oil liquid is 3-(2,5-dihydro) furan boronic acid ester.
From embodiment 1, preparing 3-(2,5 dihydros) furane sulfonic acid ester weight is 100.08g, productive rate 80%, GC>98%, 1H NMR (CDCl3): 4.62ppm, bimodal (2H); 4.81ppm, bimodal (2H); 6.61ppm, unimodal (1H); Prepare 3-(2,5-dihydro) furan boronic acid ester 40.83g, yield 78%, GC>98%, 1HNMR (CDCl 3): 1.25ppm, unimodal (12H); 4.61ppm, bimodal (2H); 4.66ppm, bimodal (2H); 6.45ppm, unimodal (1H).
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (6)

1. synthesize a 3-(2,5-dihydro) method of furan boronic acid ester, comprise 3-(2,5-dihydro) preparation of furane sulfonic acid ester and 3-(2,5-dihydro) synthesis of furan boronic acid ester, it is characterized in that:
1. 3-(2; 5-dihydro) preparation of furane sulfonic acid ester: under nitrogen protection; 50g is added, 0.58mol 3-(2,5-dihydro in 1L reaction flask) furanone and the anhydrous THF of 200mL; be chilled to-78 DEG C; then drip 376mL, 0.64mol, 1.7N are at the diisopropylamine lithium of anhydrous THF; reaction reacts 2h at-78 DEG C; be added dropwise to 163.9g again, 0.58mol tri-fluorosulfonic anhydride, dropwises; reaction solution is allowed slowly to rise to room temperature; whole process need 12h, with 10% sodium hydroxide cancellation reaction, adds 1L ether dilute reaction solution; be separated organic phase, use anhydrous MgSO 4drying, underpressure distillation, except desolventizing, under the vacuum condition of 12mmHg, is collected 45 ~ 50 DEG C of cuts, is namely obtained 3-(2,5-dihydro) furane sulfonic acid ester;
2. 3-(2; 5-dihydro) synthesis of furan boronic acid ester: under nitrogen protection; 64g is added, 0.29mol 3-(2,5-dihydro in 1L reaction flask) furane sulfonic acid ester; 74.5g; purity is the 0.29mol connection boric acid ester of 98%, 73.1g, 0.87mol salt of wormwood; and 6.43g, 0.09mol catalyst P d (dppf) Cl 2, and solvent 500mL Isosorbide-5-Nitrae-dioxane, in reaction solution, blast nitrogen 10min, then slow under a nitrogen reaction system is warming up to 80 DEG C, allow system react 16h at this temperature, be chilled to room temperature, filter, removal of solvent under reduced pressure, residue dress on a silica gel column, with normal hexane: ethyl acetate=10:1 eluted product, distillation, except desolventizing, obtains colourless oil liquid, obtains product.
2. synthesis 3-(2,5-dihydro as claimed in claim 1 a kind of) method of furan boronic acid ester, it is characterized in that: described whole reaction is carried out in normal pressure inert nitrogen gas.
3. synthesis 3-(2,5-dihydro as claimed in claim 1 a kind of) method of furan boronic acid ester, it is characterized in that: described 1. in, 3-(2,5-dihydro) mol ratio of furanone and diisopropylamine lithium and three fluorosulfonic anhydride is: 1:1.1:1.
4. synthesis 3-(2,5-dihydro as claimed in claim 1 a kind of) method of furan boronic acid ester, it is characterized in that: described step 1. in, raw material and intermediate product 3-(2,5-dihydro) the GC content ratio of furane sulfonic acid ester is less than 1% judgement reaction end.
5. synthesis 3-(2,5-dihydro as claimed in claim 1 a kind of) method of furan boronic acid ester, it is characterized in that: described step 2. in, intermediate product 3-(2,5-dihydro) the GC content ratio of furane sulfonic acid ester and final product is less than 1% judgement reaction end.
6. synthesis 3-(2,5-dihydro as claimed in claim 1 a kind of) method of furan boronic acid ester, it is characterized in that: described in the 3-(2 for preparing, 5-dihydro) furan boronic acid ester is applied as medicine intermediate.
CN201410166801.5A 2014-04-24 2014-04-24 A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester Expired - Fee Related CN103965232B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410166801.5A CN103965232B (en) 2014-04-24 2014-04-24 A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410166801.5A CN103965232B (en) 2014-04-24 2014-04-24 A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester

Publications (2)

Publication Number Publication Date
CN103965232A CN103965232A (en) 2014-08-06
CN103965232B true CN103965232B (en) 2015-09-23

Family

ID=51235281

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410166801.5A Expired - Fee Related CN103965232B (en) 2014-04-24 2014-04-24 A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester

Country Status (1)

Country Link
CN (1) CN103965232B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011084402A1 (en) * 2009-12-21 2011-07-14 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011084402A1 (en) * 2009-12-21 2011-07-14 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Novel Synthesis of Cyclic Alkenylboronates via Ring-Closing Metathesis;Johanne Renaud and Stephane G. Ouellet;《Journal of the American Chemical Society》;19980724;第120卷(第31期);7995-7996 *

Also Published As

Publication number Publication date
CN103965232A (en) 2014-08-06

Similar Documents

Publication Publication Date Title
CN111420709B (en) Application of N-heterocyclic carbene-based mixed nickel (II) complex in synthesis of 2-linear alkyl benzothiazole compound
CN102850325B (en) Preparation method of Dabigatran etexilate key intermediate
WO2011035532A1 (en) Preparation method of aromatic borate ester compound
CN104910104B (en) A kind of method of utilization copper catalysis synthesizing dihydro furan derivatives
CN103553860B (en) Method for synthesizing sulfamide compounds
CN103664821B (en) A kind of benzothiazole compound preparation method based near amino thiophenols cyclisation
CN103965232B (en) A kind of method of synthesis 3-(2,5-dihydro) furan boronic acid ester
CN103073421A (en) High-efficiency simple synthetic method for delta-chlorobutyl ester
CN107915653B (en) Method for preparing amide by catalyzing ester and amine to react
CN111217847B (en) Thiosilane ligand, preparation method thereof and application thereof in aryl boronization catalytic reaction
CN104610333A (en) Method for preparing tetrahydropyran-3-potassium trifluoroborate
CN109942432B (en) Triaryl methanol compound and synthetic method thereof
Xu et al. Highly enantioselective addition of methyl propiolate to aldehydes catalyzed by a titanium (IV) complex of a β-hydroxy amide
JP2012097082A (en) Copper-catalyzed process for production of substituted or unsubstituted trifluoromethylated aryl and heteroaryl compound
CN107880015B (en) Synthetic method of 3-bromo-2-aminothiophene
CN105439969A (en) Method for preparing 3,5-dioxo-1,2,4-triazole
Jia et al. Me3Ga-mediated alkynylation of aldehydes
WO2015144832A1 (en) Process of production of 1-(5,5-dimethylcyclohex-1-en-1-yl)ethanone and 1-(5,5-dimethylcyclohex-6-en-1-yl)ethanone
CN104672261A (en) Method for preparing tetrahydrofuran-3-boric acid pinacol ester
CN104496913A (en) Method for preparing 5-substituted-2,4-dimethylsulfenyl pyrimidine
CN110724064B (en) Method for synthesizing 2-cyclohexane substituted benzamide under catalysis of nickel
CN104610332B (en) A method of preparing three potassium fluoborate of tetrahydrofuran -3-
CN116199570B (en) Preparation method of 2, 7-dimethyl-2, 4, 6-octatriene-1, 8-dialdehyde
CN104592278A (en) Method for preparing tetrahydropyrane-3-boronic acid pinacol ester
CN107556269B (en) Synthetic method of alpha-alkynyl substituted ether compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150923

CF01 Termination of patent right due to non-payment of annual fee